Please assess the completion status of the following clinical trial:

Trial Title: Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Diabetes mellitus Type 1 or 2~* Peripheral occlusive arterial disease stage III or IV (Fontaine) with chronical ischemia, chronic foot ulcer, degree of severity \<5 (Wagner), older than 6 weeks, without acute wound infection~* Ulcer size 1 - 30cm2, in case of osteomyelitis only one bone should be affected no trend towards healing in the ulcer after one week of standard treatment~* Angiopathic or angioneuropathic diabetic foot syndrome with no possible option of operative or interventional revascularisation~* Age 18 - 80 years~* Declaration of patient consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- control group (Type: NO_INTERVENTION): patients received standard of care wound treatment according guideline of the American Diabetes Association (ADA)
- bone marrow stem cells intraarterial (Type: ACTIVE_COMPARATOR): bone marrow stem cells administered intraarterial
- tissue repair cells intramuscular (Type: ACTIVE_COMPARATOR): expanded bone marrow cells enriched in CD90+ mesenchymal stem cells administered intramuscular
- tissue repair cells intraarterial (Type: ACTIVE_COMPARATOR): expanded bone marrow cells enriched in CD90+ mesenchymal stem cells administered intraarterial
- bone marrow stem cells intramuscular (Type: ACTIVE_COMPARATOR): bone marrow stem cells administered intramuscular

Based on this trial design, predict the completion outcome and termination type (if applicable).